Hyfusin Group Holdings Limited (8512.HK)
HKD 0.31
(0.0%)
HKD 0.31
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 196.91 Million HKD | 73.59% |
| 2022 | 113.43 Million HKD | -15.17% |
| 2021 | 133.72 Million HKD | 44.9% |
| 2020 | 92.29 Million HKD | 59.34% |
| 2019 | 57.92 Million HKD | 42.22% |
| 2018 | 40.72 Million HKD | -16.43% |
| 2017 | 48.73 Million HKD | 56.81% |
| 2016 | 31.07 Million HKD | 17.07% |
| 2015 | 26.54 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 45.78 Million HKD | 0.0% |
| 2024 Q1 | 45.78 Million HKD | -65.96% |
| 2023 FY | 196.91 Million HKD | 73.59% |
| 2023 Q4 | 134.51 Million HKD | 193.65% |
| 2023 Q1 | 26.41 Million HKD | -19.39% |
| 2023 Q2 | 36.8 Million HKD | 39.37% |
| 2023 Q3 | 45.8 Million HKD | 24.45% |
| 2022 Q1 | 20.21 Million HKD | -46.08% |
| 2022 FY | 113.43 Million HKD | -15.17% |
| 2022 Q4 | 32.76 Million HKD | 7.68% |
| 2022 Q3 | 30.42 Million HKD | 6.17% |
| 2022 Q2 | 28.65 Million HKD | 41.76% |
| 2021 Q1 | 24.09 Million HKD | -42.71% |
| 2021 Q2 | 26.53 Million HKD | 10.13% |
| 2021 Q3 | 44.33 Million HKD | 67.09% |
| 2021 Q4 | 37.49 Million HKD | -15.43% |
| 2021 FY | 133.72 Million HKD | 44.9% |
| 2020 Q2 | 16.17 Million HKD | 12.13% |
| 2020 Q1 | 14.42 Million HKD | 14.21% |
| 2020 Q3 | 19.42 Million HKD | 20.1% |
| 2020 Q4 | 42.05 Million HKD | 116.43% |
| 2020 FY | 92.29 Million HKD | 59.34% |
| 2019 Q4 | 12.63 Million HKD | -32.51% |
| 2019 FY | 57.92 Million HKD | 42.22% |
| 2019 Q3 | 18.71 Million HKD | 42.11% |
| 2019 Q2 | 13.17 Million HKD | -1.73% |
| 2019 Q1 | 13.4 Million HKD | 3.45% |
| 2018 Q3 | 10.17 Million HKD | 12.04% |
| 2018 Q1 | 8.52 Million HKD | -42.97% |
| 2018 Q4 | 12.95 Million HKD | 27.37% |
| 2018 FY | 40.72 Million HKD | -16.43% |
| 2018 Q2 | 9.07 Million HKD | 6.51% |
| 2017 Q3 | 12.75 Million HKD | 18.0% |
| 2017 Q1 | 10.49 Million HKD | 0.0% |
| 2017 Q2 | 10.8 Million HKD | 3.0% |
| 2017 Q4 | 14.94 Million HKD | 17.19% |
| 2017 FY | 48.73 Million HKD | 56.81% |
| 2016 FY | 31.07 Million HKD | 17.07% |
| 2015 FY | 26.54 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 3.515% |
| Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -1279.501% |
| China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -413.763% |
| Prosperous Future Holdings Limited | 118.15 Million HKD | -66.66% |
| Huasheng International Holding Limited | 153.46 Million HKD | -28.311% |
| Fourace Industries Group Holdings Limited | 57.65 Million HKD | -241.526% |
| Evergreen Products Group Limited | 152.17 Million HKD | -29.4% |
| EC Healthcare | 597.44 Million HKD | 67.041% |
| Ming Fai International Holdings Limited | 357.68 Million HKD | 44.948% |
| Blue Moon Group Holdings Limited | 4.4 Billion HKD | 95.535% |
| SuperRobotics Holdings Limited | 15.16 Million HKD | -1198.793% |
| Takbo Group Holdings Limited | 65.71 Million HKD | -199.629% |